Do More With Reuters
Partner Services

Company Profile For TERUMO CORPORATION

TERUMO CORPORATION (4543.T) (Tokyo Stock Exchange)
sector: Healthcare · industry: Medical Equipment, Supplies & Distribution ·
As of  5:45am IST
4,820JPY
Price Change
-100
Percent Change
-2.03%
 
Research a stock:   symbol lookup
 

Overview

TERUMO CORPORATION is a Japan-based manufacturer that operates in three business segment. The General Hospital Product segment is engaged in the manufacture, importation and sale of hospital medical equipment, pharmaceuticals and blood transfusion-related products. The Cardiac and Vascular Product segment is involved in the manufacture, importation and sale of catheter systems, artificial heart lungs and artificial blood vessels, the research and development of auxiliary artificial heart. The Home Healthcare Product segment manufactures and sells peritoneal dialysis- and diabetes-related products. The Company has 38 subsidiaries and two associated companies.

Quick Financial Synopsis

BRIEF: For the six months ended 30 September 2009, TERUMO CORPORATION's revenues increased 1% to Y158.06B. The Company's net income decreased 10% to Y20.77B. Revenues reflect higher sales from transfusion related goods business. Net income is offset by a higher percentage of cost of sales, the presence of Y755M foreign exchange losses, and decreased interest income. The Company is located in Tokyo, Japan.

Company Address

TERUMO CORPORATION
2-44-1, Hatagaya
Shibuya-ku   TKY   151-0072
P: +813.33748111

Total Employees

13352

Find Out More About 4543.T

Market Update

  • IndiaIndia
  • USUS
  • UKUK
  • Asia
  • Most Actives

Commodities

Commodity Last Pct Chg Trade Date/Time
Oil 76.99 -1.88% 11/26 05:30 IST
Gold 1188.1 -0.40% 11/27 05:38 IST